General - Press Releases

Date	Title	Company
15-May-2023	Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates	Businesswire
15-May-2023	Melinta Therapeutics and Xediton Pharmaceuticals Announce Licensing Agreement to Commercialize Anti-Infective Products in Canada	Businesswire
15-May-2023	Regen Lab Announces the Obtention of the New CE Certification Under Medical Device Regulation (EU MDR 2017/745) Validating the Safety and Performance of Its Proprietary Best-in-class PRP Solutions, Alone or Combined With Hyaluronic Acid	Businesswire
15-May-2023	AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Available in the U.S.	Businesswire
15-May-2023	Therini Bio Initiates First-In-Human Dosing in Phase 1 Trial of THN391, a Fibrin-Targeting Therapeutic Candidate for Alzheimer’s Disease	Businesswire
15-May-2023	CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA	Businesswire
15-May-2023	bioAffinity Technologies Reports First Quarter 2023 Financial Results	Businesswire
15-May-2023	Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists	Businesswire
15-May-2023	Mara Makes 2023 Canada’s Sustainability Changemaker’s List	Businesswire
15-May-2023	NEUPATH ANNOUNCES THE POSITIVE RESOLUTION OF ITS OUTSTANDING HST MATTER WITH THE CRA	Businesswire
15-May-2023	Angelini Pharma’s Cenobamate▼ receives approval in Ireland for use in adults with focal onset seizures in adult patients with epilepsy	Angelini Pharma UK-I
15-May-2023	Castle Biosciences’ TissueCypher® Barrett's Esophagus Test Receives 2023 MedTech Breakthrough Award for Artificial Intelligence Innovation	Businesswire
15-May-2023	Can-Fite: Presenting Namodenoson’s New Pancreatic Cancer Indication to Potential Partners at BioEquity Europe 2023	Businesswire
15-May-2023	Apnimed to Present Positive Phase 2b Results on AD109, an Investigational Oral Treatment for Obstructive Sleep Apnea, at ATS 2023	Businesswire
15-May-2023	ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity	Businesswire
15-May-2023	Modiv Announces First Quarter 2023 Results	Businesswire
15-May-2023	Global Antimicrobial Susceptibility Testing Market Report 2023: Sector is Expected to Reach $5.08 Billion by 2030 at a CAGR of 5.1% - ResearchAndMarkets.com	Businesswire
15-May-2023	New Version of Tridion Unites Web Content, Structured Content and Headless Delivery in Industry First	Businesswire
15-May-2023	AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio	Newswire
15-May-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire